Allison Park, PA, United States of America

Bonnie Lynn Hall

This inventor holds 1 USPTO granted patent. Top assignees: University of Pennsylvania, University of Pittsburgh. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bonnie Lynn Hall. Retrieved from https://idiyas.com/inventor/bonnie-lynn-hall

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Bonnie Lynn Hall

Introduction

Bonnie Lynn Hall is a notable inventor based in Allison Park, PA (US). She has made significant contributions to the field of medical research, particularly in the development of oncolytic viruses. Her work focuses on creating antigenically stealthed HSV particles, which have potential applications in cancer treatment.

Latest Patents

Bonnie Lynn Hall holds 1 patent for her invention titled "Antigenically Stealthed Oncolytic Viruses." This patent details the methods of use for antigenically stealthed HSV particles, showcasing her innovative approach to enhancing the efficacy of viral therapies in oncology.

Career Highlights

Throughout her career, Bonnie has been associated with prestigious institutions such as the University of Pittsburgh and the University of Pennsylvania. Her work at these universities has allowed her to explore groundbreaking research in the field of virology and cancer treatment.

Collaborations

Bonnie has collaborated with esteemed colleagues, including Joseph C. Glorioso, III, and Gary H. Cohen. These partnerships have contributed to the advancement of her research and the development of her patented technologies.

Conclusion

Bonnie Lynn Hall's innovative work in the field of oncolytic viruses exemplifies her dedication to advancing medical science. Her contributions have the potential to impact cancer treatment significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…